Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Insulin Glargine Injection

Approval Number

国药准字S20201000

Company赛诺菲（北京）制药有限公司

Registration Date

February 5, 2020

Drug Information

Generic Name

甘精胰岛素注射液

Dosage Form

注射剂

Strength

3ml:300单位/笔芯

Drug Type

生物制品

Registration Date

February 5, 2020

Company Information

Applicant Company

Company Name赛诺菲（北京）制药有限公司

Company Address

北京市北京经济技术开发区兴盛街7号

Manufacturing Company

Company Name赛诺菲（北京）制药有限公司

Company Address

北京市北京经济技术开发区兴盛街7号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

甘精胰岛素注射液 - NMPA 批准文号 | MedPath